KLC
TNDM icon

Kent Lake Capital’s Tandem Diabetes Care TNDM Stock Holding History

Kent Lake Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,000
Closed -$674K – 49
2022
Q4 		$674K Buy
+15,000
New +$679K 0.4% 33

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kent Lake Capital's TNDM Position: Q1 2023 in Review

Kent Lake Capital sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 15,000 shares — an estimated $674K sold.

Kent Lake Capital first reported a position in TNDM in Q4 2022 and held it in 1 quarter. The position peaked at $674K in Q4 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Kent Lake Capital reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Kent Lake Capital sold 15,000 Tandem Diabetes Care shares in Q1 2023, an estimated $674K.
  • Kent Lake Capital first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 1 quarter.
  • Kent Lake Capital's Tandem Diabetes Care position peaked at $674K in Q4 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Kent Lake Capital's 13F filing for Q1 2023, filed 15 May 2023.